Switch to:
More From Other Websites
OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : March 29, 2017 Mar 29 2017
ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors Mar 28 2017
OPKO HEALTH, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Mar 23 2017
Opko Gets Orphan Status for Genetic Disorder Drug Mar 22 2017
OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological... Mar 22 2017
OPKO Health's GeneDx to have Significant Presence at ACMG 2017 Mar 14 2017
OPKO Health to Participate in the Barclays Global Healthcare Conference Mar 14 2017
Biotech's Rally in 2017 Stumbles on Pricing Concerns: Today's Research Reports on Opko Health and... Mar 09 2017
OPKO HEALTH, INC. Financials Mar 08 2017
OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest Mar 08 2017
OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological... Mar 08 2017
Opko Health subsidiary launches prenatal testing tool Mar 07 2017
OPKO Health, Inc. :OPK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
OPKO Subsidiary GenPath Women’s Health Announces the Availability of ClariTest™ Mar 07 2017
OPKO Health, Inc. :OPK-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 Mar 06 2017
OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research... Mar 03 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK